Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream [Letter] by Mazzetti A, Kyeremateng K, Moro L

Get full text

La transferencia epistemológica de un modelo didáctico analógico by Viau, J.E., Moro, L.E., Zamorano, R.O., Gibbs, H.M.

Get full text

Induction of Clinical and Endoscopic Remission of Mild to Moderately Active Ulcerative Colitis With Budesonide MMX (R) 9 mg: Analysis of Pooled Data from Two Phase 3 Studies by Sandborn, W, Travis, S, Bala, N, Danese, S, Moro, L, Ballard, E, Gautille, T, Bagin, B, Huang, M

Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study. by Sandborn, W, Travis, S, Moro, L, Jones, R, Gautille, T, Bagin, R, Huang, M, Yeung, P, Ballard, E

Ocorrência de apoptose em leucócitos no esfregaço de sangue periférico e em sincícios na infecção in vivo pelo vírus da cinomose canina by Moro L., Alves C.M., Santos F.G.A., Nunes J.E.S., Carneiro R.A., Vasconcelos A.C.

Get full text

Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies. by Sandborn, W, Danese, S, D'Haens, G, Moro, L, Jones, R, Bagin, R, Huang, M, David Ballard, E, Masure, J, Travis, S

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study. by Travis, S, Danese, S, Kupcinskas, L, Alexeeva, O, D'Haens, G, Gibson, P, Moro, L, Jones, R, Ballard, E, Masure, J, Rossini, M, Sandborn, W

Budesonide MMX® for the induction of remission of mild to moderate ulcerative colitis: a pooled safety analysis. by Lichtenstein, G, Travis, S, Danese, S, D'Haens, G, Moro, L, Jones, R, Huang, M, Ballard, E, Bagin, R, Hardiman, Y, Collazo, R, Sandborn, W